Allianz Asset Management Gmb H Alnylam Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 26,806 shares of ALNY stock, worth $6.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,806

Previous 18,174 47.5%

Holding current value

$6.31 Million

Previous $4.42 Million 66.96%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$233.81 - $287.01 $2.02 Million - $2.48 Million	8,632 Added 47.5%	26,806 $7.37 Million
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $954,444 - $1.65 Million	6,660 Added 57.84%	18,174 $4.42 Million
Q1 2024 May 13, 2024	SELL	$146.51 - $198.2 $333,310 - $450,905	-2,275 Reduced 16.5%	11,514 $1.72 Million
Q4 2023 Feb 12, 2024	SELL	$151.41 - $196.57 $100,233 - $130,129	-662 Reduced 4.58%	13,789 $2.64 Million
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $366,130 - $453,777	-2,144 Reduced 12.92%	14,451 $2.56 Million
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $379,640 - $435,126	-2,052 Reduced 11.0%	16,595 $3.15 Million
Q1 2023 May 11, 2023	BUY	$182.66 - $235.53 $53,702 - $69,245	294 Added 1.6%	18,647 $3.74 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $628,946 - $818,040	-3,390 Reduced 15.59%	18,353 $4.36 Million
Q3 2022 Nov 08, 2022	SELL	$138.54 - $232.0 $3.87 Million - $6.49 Million	-27,968 Reduced 56.26%	21,743 $4.35 Million
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $575,968 - $809,714	4,783 Added 10.65%	49,711 $7.25 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $780,376 - $1.07 Million	-6,136 Reduced 12.02%	44,928 $7.34 Million
Q4 2021 Feb 11, 2022	SELL	$159.56 - $209.29 $716,424 - $939,712	-4,490 Reduced 8.08%	51,064 $8.67 Million
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $3.56 Million - $4.35 Million	20,955 Added 60.57%	55,554 $10.5 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $367,881 - $505,905	-2,860 Reduced 7.64%	34,599 $5.87 Million
Q1 2021 May 13, 2021	BUY	$126.83 - $175.69 $944,249 - $1.31 Million	7,445 Added 24.81%	37,459 $5.29 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $196,137 - $234,465	-1,595 Reduced 5.05%	30,014 $3.9 Million
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $848,572 - $1.16 Million	-7,002 Reduced 18.13%	31,609 $4.6 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $543,350 - $815,678	-5,214 Reduced 11.9%	38,611 $5.72 Million
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $1.39 Million - $1.99 Million	-14,881 Reduced 25.35%	43,825 $4.77 Million
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $2.18 Million - $3.63 Million	-29,211 Reduced 33.23%	58,706 $6.76 Million
Q3 2019 Nov 13, 2019	SELL	$70.9 - $87.82 $1.19 Million - $1.47 Million	-16,736 Reduced 15.99%	87,917 $7.09 Million
Q2 2019 Aug 08, 2019	SELL	$65.86 - $92.79 $1.27 Million - $1.79 Million	-19,274 Reduced 15.55%	104,653 $7.59 Million
Q1 2019 May 13, 2019	SELL	$72.76 - $93.45 $1.74 Million - $2.23 Million	-23,886 Reduced 16.16%	123,927 $11.6 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $1.67 Million - $2.35 Million	-26,637 Reduced 15.27%	147,813 $10.7 Million
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $3.39 Million - $4.75 Million	38,720 Added 28.53%	174,450 $15.3 Million
Q2 2018 Aug 13, 2018	BUY	$88.31 - $107.8 $5.65 Million - $6.9 Million	63,975 Added 89.16%	135,730 $13.4 Million
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $11,592 - $14,854	100 Added 0.14%	71,755 $8.55 Million
Q4 2017 Feb 13, 2018	BUY	$114.49 - $139.98 $5.11 Million - $6.25 Million	44,655 Added 165.39%	71,655 $9.1 Million
Q3 2017 Nov 13, 2017	SELL	$72.53 - $118.27 $230,427 - $375,743	-3,177 Reduced 10.53%	27,000 $3.17 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,177 Added 11.77%	30,177 $2.39 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-63,574 Reduced 70.19%	27,000 $1.01 Million
Q3 2016 Apr 17, 2019	BUY	N/A	90,574	90,574 $6.3 Million

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

108M

Call Options Held

1.15M

Put Options Held

1.07M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Alnylam Pharmaceuticals, Inc. Transaction History